The rising incidence of Gastrointestinal Stromal Tumors (GISTs) globally is a fundamental driver for the market, stimulating both diagnostic and therapeutic demand. While GIST is considered a rare cancer, its incidence is steadily increasing due to better diagnostic tools and a growing, aging global population. Epidemiological estimates often place the annual incidence at approximately 1.5 to...
Portuguese
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek